Skip to main content

Table 1 Sociodemographic and clinical characteristics of HIV-positive individuals, by cohort

From: Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study

Parameter Overall
(n = 198)
WIHS
(n = 111)
MACS
(n = 87)
Age,y 48 (41, 54) 46 (40, 53) 49 (44, 56)
Race/ethnicity
 Black 126 (64) 87 (78) 39 (45)
 White 59 (30) 15 (14) 44 (50)
 Other 13 (6) 9 (8) 4 (5)
 Hispanic 29 (15) 20 (18) 9 (10)
Smoking
 Current 73 (37) 46 (41) 27 (31)
 Past 62 (31) 25 (23) 37 (43)
 Never 62 (31) 40 (36) 22 (26)
 Diabetes mellitus 32 (17) 20 (18) 12 (17)
 Systolic BP, mmHg 126 (114, 137) 121 (110, 134) 129 (117, 137)
 Diastolic BP, mmHg 77 (71, 86) 74 (69, 85) 80 (72, 87)
 Hypertension 93 (48) 56 (50) 37 (44)
 Antihypertensive use 70 (35) 45 (41) 25 (29)
 Statin use 31 (16) 17 (15) 14 (17)
 History of CVD 13 (7) 4 (4) 9 (10)
 BMI, kg/m2 27 (23, 32) 29 (24, 34) 25 (23, 28)
 Waist Circumference, cm 94 (83, 104) 96 (82, 106) 92 (84, 102)
 Current HAART 66 (33) 31 (28) 35 (40)
 Current NRTI 67 (34) 31 (28) 36 (41)
 Current NNRTI 34 (17) 13 (12) 21 (24)
 Current PI 30 (15) 14 (13) 16 (18)
 Current CD4+ count, cells/mm3 483 (338, 682) 485 (314, 667) 465 (387, 716)
 History of AIDS 26 (13) 23 (21) 3 (3)
 Current HIV RNA, <  80 copies/mL 56 (29) 24 (22) 32 (37)
 Hepatitis C virus seropositive 33 (17) 20 (18) 13 (15)
 Estimated GFR 103 (88, 116) 103 (85, 117) 104 (92, 116)
 ACR,mg/g 3.2 (1.9, 7.1) 3.5 (2.0, 12.0) 3.0 (1.8, 5.7)
  1. Data are presented as Median (IQR) or numbers (percent). WIHS Women’s Interagency HIV Study, MACS Multicenter AIDS Cohort Study, BP Blood pressure, CVD Cardiovascular disease, BMI Body Mass Index, HAART Highly active antiretroviral therapy, NRTI Nucleoside Reverse Transcriptase Inhibitors, NNRTI Non-Nucleoside Reverse Transcriptase Inhibitors, PI Protease inhibitors, GFR Glomerular filtration rate, ACR albumin to creatinine ratio